Italy In-Vitro Diagnostic Market is predicted to reach USD 1.93 Billion by 2030

According to the study by Next Move Strategy Consulting, the Italy In-Vitro Diagnostics Market size is predicted to reach USD 1.93 billion, at a CAGR of 3.0% by 2030.

Request a FREE Sample: https://www.nextmsc.com/italy-in-vitro-diagnostic-market/request-sample

The considerable increase in healthcare spending plays a pivotal role in propelling the growth of the in-vitro diagnostics market in Italy.

the integration of Information and Communications Technology (ICT) in healthcare is emerging as a significant driver for the growth of in-vitro diagnostics market in Italy.

The promising players operating in the Italy in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.